These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 16309971)

  • 1. Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells.
    Jia SJ; Jiang DJ; Hu CP; Zhang XH; Deng HW; Li YJ
    Vascul Pharmacol; 2006 Mar; 44(3):143-8. PubMed ID: 16309971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity.
    Jiang JL; Zhang XH; Li NS; Rang WQ; Feng-Ye ; Hu CP; Li YJ; Deng HW
    Cardiovasc Drugs Ther; 2006 Aug; 20(4):281-94. PubMed ID: 16897158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
    Feng M; Liu L; Guo Z; Xiong Y
    Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of neferine on endothelial cell nitric oxide production induced by lysophosphatidylcholine: the role of the DDAH-ADMA pathway.
    Peng ZY; Zhang SD; Liu S; He BM
    Can J Physiol Pharmacol; 2011 Apr; 89(4):289-94. PubMed ID: 21526974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ADMA/DDAH/NO pathway in human vein endothelial cells exposed to arsenite.
    Osorio-Yáñez C; Chin-Chan M; Sánchez-Peña LC; Atzatzi-Aguilar OG; Olivares-Reyes JA; Segovia J; Del Razo LM
    Toxicol In Vitro; 2017 Aug; 42():281-286. PubMed ID: 28502835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRMT-1 and DDAHs-induced ADMA upregulation is involved in ROS- and RAS-mediated diabetic retinopathy.
    Chen Y; Xu X; Sheng M; Zhang X; Gu Q; Zheng Z
    Exp Eye Res; 2009 Dec; 89(6):1028-34. PubMed ID: 19748504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric dimethylarginine damages connexin43-mediated endothelial gap junction intercellular communication.
    Jia SJ; Zhou Z; Zhang BK; Hu ZW; Deng HW; Li YJ
    Biochem Cell Biol; 2009 Dec; 87(6):867-74. PubMed ID: 19935872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway.
    Tan B; Jiang DJ; Huang H; Jia SJ; Jiang JL; Hu CP; Li YJ
    Vascul Pharmacol; 2007 May; 46(5):338-45. PubMed ID: 17293168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the endothelial DDAH/ADMA pathway in nitroglycerin tolerance: the role of ALDH-2.
    Zhang GG; Shi RZ; Jiang DJ; Chen YR; Jia-Chen ; Tang ZY; Bai YP; Xiao HB; Li YJ
    Life Sci; 2008 Mar; 82(13-14):699-707. PubMed ID: 18289604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Icariin regulates PRMT/ADMA/DDAH pathway to improve endothelial function.
    Xiao HB; Liu ZK; Lu XY; Deng CN; Luo ZF
    Pharmacol Rep; 2015 Dec; 67(6):1147-54. PubMed ID: 26481534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation by DDAH/ADMA pathway of lipopolysaccharide-induced tissue factor expression in endothelial cells.
    Xin HY; Jiang DJ; Jia SJ; Song K; Wang GP; Li YJ; Chen FP
    Thromb Haemost; 2007 May; 97(5):830-8. PubMed ID: 17479195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neferine protects endothelial cells against damages induced by LPC and relationship with asymmetric dimethylarginine].
    Zhang SD; Peng ZY; Liu S; Pei ZF; Chen F; Yang L
    Zhongguo Zhong Yao Za Zhi; 2008 Nov; 33(21):2526-9. PubMed ID: 19149265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of resveratrol derivative BTM-0512 on high glucose-induced cell senescence involves dimethylaminohydrolase/asymmetric dimethylarginine pathway.
    Yuan Q; Peng J; Liu SY; Wang CJ; Xiang DX; Xiong XM; Hu CP; Li YJ
    Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):630-5. PubMed ID: 20132235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of nebivolol on asymmetric dimethylarginine system in spontaneously hypertension rats.
    Wang Y; Zhang M; Liu Y; Liu Y; Chen M
    Vascul Pharmacol; 2011; 54(1-2):36-43. PubMed ID: 21167314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estradiol, acting through estrogen receptor alpha, restores dimethylarginine dimethylaminohydrolase activity and nitric oxide production in oxLDL-treated human arterial endothelial cells.
    Novella S; Laguna-Fernández A; Lázaro-Franco M; Sobrino A; Bueno-Betí C; Tarín JJ; Monsalve E; Sanchís J; Hermenegildo C
    Mol Cell Endocrinol; 2013 Jan; 365(1):11-6. PubMed ID: 22982060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophosphatidylcholine-induced modulation of Ca(2+)-activated K(+)channels contributes to ROS-dependent proliferation of cultured human endothelial cells.
    Wolfram Kuhlmann CR; Wiebke Lüdders D; Schaefer CA; Kerstin Most A; Backenköhler U; Neumann T; Tillmanns H; Erdogan A
    J Mol Cell Cardiol; 2004 May; 36(5):675-82. PubMed ID: 15135662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
    Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of kaempferol against endothelial damage by an improvement in nitric oxide production and a decrease in asymmetric dimethylarginine level.
    Xiao HB; Jun-Fang ; Lu XY; Chen XJ; Chao-Tan ; Sun ZL
    Eur J Pharmacol; 2009 Aug; 616(1-3):213-22. PubMed ID: 19549512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease.
    Matsuguma K; Ueda S; Yamagishi S; Matsumoto Y; Kaneyuki U; Shibata R; Fujimura T; Matsuoka H; Kimoto M; Kato S; Imaizumi T; Okuda S
    J Am Soc Nephrol; 2006 Aug; 17(8):2176-83. PubMed ID: 16807406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variance of DDAH/PRMT/ADMA pathway in atrial fibrillation dogs.
    Liu H; Qu X; Liang Z; Chen W; Xia W; Song Y
    Biochem Biophys Res Commun; 2008 Dec; 377(3):884-8. PubMed ID: 18951871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.